What is Rheumatoid Arthritis (RA)?
This autoimmune disease causes the body’s immune system to attack the joints instead of attacking foreign substances such as bacteria and viruses. The tissue line in the joints thickens which results in swelling and pain around the joints and the inflammation can damage cartilage and bones if it goes unchecked. Rheumatoid arthritis sufferers will fell their joints become tender, warm, and swollen. They can oftentimes feel fatigued, have fevers, and even lose their appetites. Over time, patients with RA can lose mobility due to the loss of cartilage and bone.
The damage caused by this disease cannot be reversed. When caught early on, doctors will use aggressive treatments to control the rheumatoid arthritis symptoms and possibly stop the disease from progressing. The medication will reduce or stop the inflammation and then target remission. Doctors will use medications to ease the symptoms and focus on preventing future inflammation.
How Can Marijuana Help?
Though there are medications out there that help patients diagnosed with rheumatoid arthritis to recover and can alter the course of the disease, medical marijuana can act as a complementary medicine therapy for patients. Marijuana can be used as an anti-inflammatory and help patients with chronic pain. There is no much research around the effects of marijuana helping rheumatoid arthritis patients due to their other methods of treating them. But with marijuana become more widely accepted as a form of medical treatment or therapy, the research will need to be done.
Approximately 1.5 million people in the United States are suffering from RA. More research is being done in the medical field involving the use of medical marijuana. Companies are searching for new uses and treatment options that involve medical marijuana. At the forefront, MMJ International Holdings is working to become FDA approved with their treatments of Multiple Sclerosis and Huntington’s Disease.
“We meet the public interest requirement evidenced by our filings with the FDA, in our development of a cannabis-based drug to treat Multiple Sclerosis and Huntington’s Disease. We have applied for the DEA bulk manufacturing license to continue our development of an FDA-approved pharmaceutical,” says Duane Boise.
In the near future, MMJ could obtain a federal license to cultivate medical marijuana, opening up more possibilities to improve marijuana research.